ReviewMedical oncology (Northwood, London, England)2025
A comprehensive review on the role of plant-derived bioactive metabolites driving ROS-mediated apoptosis in cancer.
Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Phytochemical Analysis Using LC-MS/MS and Anticancer Activity of Asphodelus tenuifolius Roots: Cell Cycle Arrest, Apoptosis, and In Silico Insights.Chemistry & biodiversity · 2026Article
- Cytotoxic Effects of Medicinal Plant Extracts on HeLa Cells via Redox Imbalance, L-Arginine Metabolic Reprogramming, and Glycolytic Suppression.Cell biochemistry and function · 2026Article
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis.Antioxidants (Basel, Switzerland) · 2026Review
- Plant-Derived Natural Products and Selective Apoptosis: A Cancer-Cell Vulnerability-State Framework from Redox Imbalance to Membrane-Ion Dysregulation.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Dietary Polyphenols (Flavonoids) Derived from Plants for Use in Therapeutic Health: Antioxidant Performance, ROS, Molecular Mechanisms, and Bioavailability Limitations.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive Oxygen Species (ROS) are essential in inducing cancer cell death through the promotion of oxidative stress, DNA damage, and the disturbance of cellular homeostasis. Natural bioactive chemicals sourced from plants and other natural products are significant for their capacity to selectively regulate ROS levels and cause apoptosis in cancer cells while sparing normal cells. The study gives a thorough summary of the molecular mechanisms of ROS-induced apoptosis, including mitochondrial damage, pro-apoptotic pathway activation, and inhibition of anti-apoptotic proteins. The review focuses on several natural bioactive molecules, such as polyphenols, flavonoids, alkaloids, and terpenoids that have anticancer activity through ROS induction. The potential therapeutic application of the compounds in increasing the effectiveness of standard cancer therapies and reducing drug resistance is likewise discussed. In addition, the review discusses the challenge of clinical translation of these bioactive compounds with respect to bioavailability, stability, and site-specific delivery. In conclusion, this review highlights the promising potential of ROS-modulating bioactive compounds as a new therapeutic strategy for cancer treatment, with insights into their mechanistic action and therapeutic implications.
Indexed as
Identifiers
40782283What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.